More than 200 patients have had their lung disease treatment reviewed following concerns their care at a Surrey hospital did not meet best practice guidance, a board report said. A review by the Royal ...
Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.
In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...
The asset at play is fipaxalparant, a candidate designed to block the lysophosphatidic acid receptor 1 (LPAR1). Amgen tested ...
Combination Treatment Improves Response to Immunotherapy ... 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying ...
A man whose brother died waiting on a double lung transplant says more work is needed to make Cystic Fibrosis drugs available ...
Under the terms of the agreement, Surrozen will provide antibody discovery services for a period of up to two years. TCGFB will own all TGF-β product related intellectual property. In exchange for ...
Met primary objective demonstrating nintedanib DPI was safe and well toleratedParticipants did not experience adverse events typically reported with oral nintedanibExpect to meet with the FDA in 1H ...
NEW YORK (WABC) -- A mother from Queens is opening up about motherhood amid her battle against an aggressive form of cancer.